FDI Clearance Has Been Received For The Directed Share Issue Of 900,000 Shares To ENDI Corp
Through the Share Issue, the Company will receive gross proceeds of SEK 20.7 million (before transaction costs). When the Share Issue has been registered with the Swedish Companies Registration Office, the number of shares and votes in the Company will increase by 900,000 shares and votes, from 6,311,041 shares and votes to 7,211,041 shares and votes. The share capital will increase by SEK 450,000.01, from SEK 3,155,520.57 to SEK 3,605,520.58.
In connection with the Share Issue, the board members of the Company Rune Rinnan, Olof Nordberg and Oskar Lindström (acting through holding companies and privately) sell all their shares, representing approx. 14.1 per cent of the total number of shares and votes in the Company before the Share Issue, to ENDI Corp (738,070 shares), Henrik Scharp (80,000 shares, through a holding company) and the board member Anders Lindqvist (70,000 shares, through a holding company) at the same price per share as the subscription price in the Share Issue. These transactions were also subject to the FDI Clearance.
The information was submitted for publication by the designated contact person below on 11 November 2025 at 21:00 (CET).
For further information, please contact:
Urban Lindskog, President and CEO
Stockwik Förvaltning AB (publ)
E-mail:...
About Stockwik
Stockwik offers a stable platform for small businesses to develop both organically and through acquisitions. Stockwik's companies offer value-adding products and services to corporate customers. Stockwik is listed on Nasdaq Stockholm Small Cap with the short name STWK.
Attachment
-
Stockwik FDI approval 251111

Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.

Comments
No comment